Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongbin Ji

Showing results (101-110 of 214) with videos related to

Pageof 22
Sort By:
Cancer Research|July 5, 2006
Non-small-cell lung cancer and Ba/F3 transformed cells harboring the ERBB2 G776insV_G/C mutation are sensitive to the dual-specific epidermal growth factor receptor and ERBB2 inhibitor HKI-272Takeshi Shimamura, Hongbin Ji, Yuko Minami, et al.
Molecular and Cellular Biology|January 24, 2006
Respiratory failure due to differentiation arrest and expansion of alveolar cells following lung-specific loss of the transcription factor C/EBPalpha in miceDaniela S Bassères, Elena Levantini, Hongbin Ji, et al.
The Journal of Biological Chemistry|May 18, 2012
MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 geneRong Fang, Tian Xiao, Zhaoyuan Fang, et al.
Nature Communications|November 4, 2023
Selective activator of human ClpP triggers cell cycle arrest to inhibit lung squamous cell carcinomaLin-Lin Zhou, Tao Zhang, Yun Xue, et al.
International Journal of Cancer|November 1, 2013
NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transitionYujuan Jin, Fei Li, Chao Zheng, et al.
Journal of Thoracic Disease|September 22, 2017
Unique distribution of programmed death ligand 1 (PD-L1) expression in East Asian non-small cell lung cancerYunjian Pan, Difan Zheng, Yuan Li, et al.
The Journal of Clinical Investigation|April 15, 2026
Therapy-induced cholesterol biosynthesis drives lung cancer dormancy and drug resistanceYikai Zhao, Yijia Zhou, Linnuo Pan, et al.
The Journal of Clinical Investigation|February 2, 2026
Retraction for Lkb1 deletion in periosteal mesenchymal progenitors induces osteogenic tumors through mTORC1 activationYujiao Han, Heng Feng, Jun Sun, et al.
Cell Reports|April 25, 2019
YAP Aggravates Inflammatory Bowel Disease by Regulating M1/M2 Macrophage Polarization and Gut Microbial HomeostasisXin Zhou, Weiyun Li, Shuang Wang, et al.
Cell Discovery|June 4, 2024
Genetic tracing uncovers the importance of epithelial-to-mesenchymal transition in small cell lung cancer chemotherapy resistance but not metastasisYuting Chen, Chenchen Guo, Xinlei Cai, et al.
Pageof 22

Showing results (101-110 of 214) with videos related to

Sort By:
Pageof 22
Cancer Research|July 5, 2006
Non-small-cell lung cancer and Ba/F3 transformed cells harboring the ERBB2 G776insV_G/C mutation are sensitive to the dual-specific epidermal growth factor receptor and ERBB2 inhibitor HKI-272Takeshi Shimamura, Hongbin Ji, Yuko Minami, et al.
Molecular and Cellular Biology|January 24, 2006
Respiratory failure due to differentiation arrest and expansion of alveolar cells following lung-specific loss of the transcription factor C/EBPalpha in miceDaniela S Bassères, Elena Levantini, Hongbin Ji, et al.
The Journal of Biological Chemistry|May 18, 2012
MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 geneRong Fang, Tian Xiao, Zhaoyuan Fang, et al.
Nature Communications|November 4, 2023
Selective activator of human ClpP triggers cell cycle arrest to inhibit lung squamous cell carcinomaLin-Lin Zhou, Tao Zhang, Yun Xue, et al.
International Journal of Cancer|November 1, 2013
NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transitionYujuan Jin, Fei Li, Chao Zheng, et al.
Journal of Thoracic Disease|September 22, 2017
Unique distribution of programmed death ligand 1 (PD-L1) expression in East Asian non-small cell lung cancerYunjian Pan, Difan Zheng, Yuan Li, et al.
The Journal of Clinical Investigation|April 15, 2026
Therapy-induced cholesterol biosynthesis drives lung cancer dormancy and drug resistanceYikai Zhao, Yijia Zhou, Linnuo Pan, et al.
The Journal of Clinical Investigation|February 2, 2026
Retraction for Lkb1 deletion in periosteal mesenchymal progenitors induces osteogenic tumors through mTORC1 activationYujiao Han, Heng Feng, Jun Sun, et al.
Cell Reports|April 25, 2019
YAP Aggravates Inflammatory Bowel Disease by Regulating M1/M2 Macrophage Polarization and Gut Microbial HomeostasisXin Zhou, Weiyun Li, Shuang Wang, et al.
Cell Discovery|June 4, 2024
Genetic tracing uncovers the importance of epithelial-to-mesenchymal transition in small cell lung cancer chemotherapy resistance but not metastasisYuting Chen, Chenchen Guo, Xinlei Cai, et al.
Pageof 22